Weight-loss Drugs

Eli Lilly Stock Eyes Worst Month Since February 2009: Is It Time To Buy The Dip?

Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

Eli Lilly's Q2 Sales Surge 36%, Analysts Cautious On Future Supply, Market Dynamics; Optimistic About Next-Gen Oral Weight-Loss Drug

EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'

Cannabis With Ozempic, Wegovy, Other Weight-Loss Drugs: Here's What You Need To Know If You're Combining Them

Miracle Or Myth? Survey Shows Americans Doubt Ozempic, Wegovy's Weight Loss Claims

Cannabis With Ozempic, Wegovy, Other Weight-Loss Drugs: Here's What You Need To Know If You're Combining Them

Miracle Or Myth? Survey Shows Americans Doubt Ozempic, Wegovy's Weight Loss Claims

Is Tesla Still A Magnificent 7 Stock? EV Maker Could Get Bumped By These Companies

Ozempic Maker Beats Bernard Arnault's LVMH As Europe's Most Valuable Firm With Stunning $423B Market Cap

Weight-loss Drugs Recent News

Ex-Fund Manager Regrets Missing The Boat On A Stock Which Rallied 16% This Week: 'I Should Have Followed My Instincts'

Whitney Tilson recalled his comments in late-2022 about 'miraculous' weight-loss drugs and said he regretted not buying Eli Lilly stock then.

After This Pharma Stock Surges To Record High, Cramer Says It's 'Going Higher Still'

Eli Lilly reported a beat-and-raise Q2 on Tuesday and its stock moving into record territory and Cramer thinks there is more upside to it.